Clinical Trial Update: Infusion of Apomorphine: Long-term Safety Study [Phase 3]

View source ↗

Summary

This is a Phase 3 long-term safety study evaluating infusion of apomorphine in idiopathic Parkinson's disease. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• Apomorphine (apomorphine)

Snippet

Sponsor: MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals | Conditions: Idiopathic Parkinson's Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING